Correlation Between Regeneron Pharmaceuticals and Procter Gamble

Can any of the company-specific risk be diversified away by investing in both Regeneron Pharmaceuticals and Procter Gamble at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regeneron Pharmaceuticals and Procter Gamble into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Regeneron Pharmaceuticals and Procter Gamble, you can compare the effects of market volatilities on Regeneron Pharmaceuticals and Procter Gamble and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regeneron Pharmaceuticals with a short position of Procter Gamble. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regeneron Pharmaceuticals and Procter Gamble.

Diversification Opportunities for Regeneron Pharmaceuticals and Procter Gamble

0.05

Correlation Coefficient

Regeneron Pharmaceuticals  Procter Gamble

Significant diversification

The 3 months correlation between Regeneron and Procter is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Regeneron Pharmaceuticals and Procter Gamble in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Procter Gamble and Regeneron Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regeneron Pharmaceuticals are associated (or correlated) with Procter Gamble. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Procter Gamble has no effect on the direction of Regeneron Pharmaceuticals i.e., Regeneron Pharmaceuticals and Procter Gamble go up and down completely randomly.

Pair Corralation between Regeneron Pharmaceuticals and Procter Gamble

Given the investment horizon of 90 days Regeneron Pharmaceuticals is expected to under-perform the Procter Gamble. In addition to that, Regeneron Pharmaceuticals is 1.57 times more volatile than Procter Gamble. It trades about -0.07 of its total potential returns per unit of risk. Procter Gamble is currently generating about 0.02 per unit of volatility. If you would invest  16,608  in Procter Gamble on December 29, 2024 and sell it today you would earn a total of  195.00  from holding Procter Gamble or generate 1.17% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Regeneron Pharmaceuticals  vs.  Procter Gamble

Regeneron Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Regeneron Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Procter Gamble

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Procter Gamble are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable technical and fundamental indicators, Procter Gamble is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Regeneron Pharmaceuticals and Procter Gamble

The main advantage of trading using opposite Regeneron Pharmaceuticals and Procter Gamble positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regeneron Pharmaceuticals position performs unexpectedly, Procter Gamble can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Procter Gamble will offset losses from the drop in Procter Gamble's long position.

The idea behind Regeneron Pharmaceuticals and Procter Gamble pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.